ANTI-GD2-ANTIKÖRPER

Patent europeic · EP3323830 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3323830
Numer da la dumonda
EP17191451
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
20-06-2011
Publitgà
23-05-2018
Concedì
23-08-2023
La protecziun finescha il pli tard
19-06-2031
Proxima taxa annuala scadenta
30-06-2027
Classas IPC
C07K 16/00 (2006.01)
A61K 39/395 (2006.01)
C12N 5/07 (2010.01)
Prioritad
US 397920 P 19.06.2010
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 04-09-2026

    Represchentant inscrit

    Representative
    Pintz & Partners LLC, c/o Frey Services, Eggstrasse 14f, 8134 Adliswil

    Published in Swissreg on 04.09.2026

  2. 01-07-2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  3. 01-07-2025

    Next annual fee due on

    Next annual fee due on
    30.06.2025 → 30.06.2026

    Published in Swissreg on 01.07.2025

  4. 04-07-2024

    Midada

    Published in Swissreg on 04.07.2024

  5. 03-07-2024

    Midada

    Published in Swissreg on 03.07.2024

  6. 23-08-2023

    Concedì

    Published in Swissreg on 23.08.2023

Partidas

Possessur

Memorial Sloan-Kettering Cancer Center

1275 York Avenue, New York, NY 10065, US

Represchentant

Pintz & Partners LLC

c/o Frey Services Eggstrasse 14f, 8134 Adliswil

Inventur

Ahmed, Mahiuddin

Corona, NY 11368, US

Cheung, Nai-Kong

Purchase, NY 10577, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.